Article Data

  • Views 212
  • Dowloads 106

Original Research

Open Access

Real-world exploration of men's involvement in contraception: an observational study in a convenience sample

  • Robin Hamal1,*,
  • Bertrand Tombal1
  • Jeanne Beirnaert2
  • Julien Van Damme1
  • Rawad Abou Zahr1
  • Thierry Roumeguère2
  • Sam Ward3
  • Mikkel Fode4
  • Gilles Adans-Dester5
  • Marcelo Di Gregorio5
  • Amandine Degraeve1,5

1Department of Urology, Clinique Universitaire Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium

2Department of Urology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, 1060 Brussels, Belgium

3Department of Urology, Clinique Saint-Jean, 1000 Brussels, Belgium

4Department of Urology, Herlev and Gentofte Hospital, 2730 Copenhagen, Denmark

5Department of Urology, CHU UCL Namur-Godinne, 5530 Yvoir, Belgium

DOI: 10.22514/jomh.2026.051 Vol.22,Issue 6,June 2026 pp.57-63

Submitted: 11 September 2025 Accepted: 18 March 2026

Published: 30 June 2026

*Corresponding Author(s): Robin Hamal E-mail: robin.hamal@azorg.be

Abstract

Background: Dependable male contraceptive options are restricted to vasectomy and condoms, with 30% of couples using male contraception. We need to update the understanding of current European and Belgian trends in couple and male contraception due to ongoing changes in practices. Methods: Between July and September 2023, 1200 men consented to participate in a phase 4, survey-based study focusing on three primary themes: the discussion, the responsibility and the utilization of male contraception in couple. Results: Five hundred and ninety-four patients responded to the study (49.5%). The findings indicated that men in Central Europe were more inclined to engage in discussions about contraception compared to their counterparts in Southern Europe. Men in the 18–25 age bracket participated more in decision-making processes. The interest diminished with age. Men possessing higher education were more inclined to engage in discussions about contraception and to share responsibilities with their spouses. Regarding participation in contraception, vasectomy was widely recognized, with approximately 75% of men expressing willingness to utilize this treatment. Condom utilization often declines with age, but vasectomy prevalence rises. Conclusions: The research underscores the necessity for enhanced knowledge and education regarding male contraception. Facilitating educated decision-making and equitable distribution of contraception is essential, particularly with the advent of novel male contraceptive techniques.


Keywords

Male contraception; Vasectomy; Phase 4 study; Discussion; Responsibility


Cite and Share

Robin Hamal,Bertrand Tombal,Jeanne Beirnaert,Julien Van Damme,Rawad Abou Zahr,Thierry Roumeguère,Sam Ward,Mikkel Fode,Gilles Adans-Dester,Marcelo Di Gregorio,Amandine Degraeve. Real-world exploration of men's involvement in contraception: an observational study in a convenience sample. Journal of Men's Health. 2026. 22(6);57-63.

References

[1] Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal contraception in Western countries: a systematic review. Social Science & Medicine. 2021; 284: 114247.

[2] Lecomte S, Habauzit D, Charlier TD, Pakdel F. Emerging estrogenic pollutants in the aquatic environment and breast cancer. Genes. 2017; 8: 229.

[3] Amouroux M, Mieusset R, Desbriere R, Opinel P, Karsenty G, Paci M, et al. Are men ready to use thermal male contraception? Acceptability in two French populations: new fathers and new providers. PLOS ONE. 2018; 13: e0195824.

[4] Le Guen M, Ventola C, Bohet A, Moreau C, Bajos N; FECOND group. Men’s contraceptive practices in France: evidence of male involvement in family planning. Contraception. 2015; 92: 46–54.

[5] Amory JK. Male contraception. Fertility and Sterility. 2016; 106: 1303–1309.

[6] World Health Organization. Mechanisms of action and effectiveness of contraceptive methods. 2025. Available at: https://cdn.who.int/media/docs/default-source/reproductive-health/contraception-family-planning/mechanisms-of-action-and-effectiveness-of-contraception-methods.pdf?sfvrsn=e39a69c2_1 (Accessed: 15 July 2025).

[7] Degraeve A, Roumeguere T, Tilmans G, Marotta ML, Huyghe E, Fournier G, et al. European countries have different rates of sperm cryopreservation before vasectomy and at the time of reversal. Andrology. 2022; 10: 1286–1291.

[8] Degraeve A, Tosco L, Tombal B, Roumeguere T, Beirnaert J, Hamal R, et al. Definition of a European pre-vasectomy scoring system to identify patients at risk of vasectomy regret. Sexual Medicine. 2025; 12: qfae094.

[9] Harsin JD, Gelino BW, Strickland JC, Johnson MW, Berry MS, Reed DD. Behavioral economics and safe sex: examining condom use decisions from a reinforcer pathology framework. Journal of the Experimental Analysis of Behavior. 2021; 116: 149–165.

[10] Glasier A. Acceptability of contraception for men: a review. Contraception. 2010; 82: 453–456.

[11] Abbe CR, Page ST, Thirumalai A. Male contraception. Yale Journal of Biology and Medicine. 2020; 93: 603–613.

[12] Joubert S, Tcherdukian J, Mieusset R, Perrin J. Thermal male contraception: a study of users’ motivation, experience, and satisfaction. Andrology. 2022; 10: 1500–1510.

[13] Liu YX. Temperature control of spermatogenesis and prospect of male contraception. Frontiers in Bioscience. 2010; 2: 730–755.

[14] Chung SS, Cuellar RA, Wang X, Reczek PR, Georg GI, Wolgemuth DJ. Pharmacological activity of retinoic acid receptor alpha-selective antagonists in vitro and in vivo. ACS Medicinal Chemistry Letters. 2013; 4: 446–450.

[15] Thirumalai A, Amory JK. Emerging approaches to male contraception. Fertility and Sterility. 2021; 115: 1369–1376.

[16] Service CA, Puri D, Hsieh TC, Patel DP. Emerging concepts in male contraception: a narrative review of novel, hormonal and non-hormonal options. Therapeutic Advances in Reproductive Health. 2023; 17: 26334941221138323.

[17] Lohiya NK, Ansari AS, Sadasukhi TC, Pachera S, Khilwani B, Dhaked RK. RISUG® offers early contraception: an experience during phase III clinical trials. Journal of Reproductive Health and Medicine. 2022; 3: 11.

[18] Hoga LA, Rodolpho JR, Sato PM, Nunes MC, Borges AL. Adult men’s beliefs, values, attitudes and experiences regarding contraceptives: a systematic review of qualitative studies. Journal of Clinical Nursing. 2014; 23: 927–939.

[19] Naranjo-Márquez M, Bocchino A, Gilart E, Cotobal-Calvo EM, Mata-Pérez C, Palazón-Fernández JL. Personality traits and sexual attitudes as predictors of risky sexual behaviors in health science students. Youth. 2026; 6: 19.

[20] Godiwala P, Appelhans BM, Moore Simas TA, Xiao RS, Liziewski KE, Pagoto SL, et al. Pregnancy intentionality in relation to non-planning impulsivity. Journal of Psychosomatic Obstetrics & Gynecology. 2016; 37: 130–136.

[21] Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology. 1995; 51: 768–774.

[22] Klugman J, Li L, Barker KM, Parsons J, Dale K. How are the domains of women’s inclusion, justice, and security associated with maternal and infant mortality across countries? Insights from the women, peace, and security index. SSM-Population Health. 2019; 9: 100486.

[23] Montay J. The WHO is raising concerns about young people’s declining use of condoms and the contraceptive pill. 2024. Available at: https://www.rtbf.be/article/l-oms-s-alarme-du-desamour-des-jeunes-pour-le-preservatif-et-la-pilule-11426145?utm_source=chatgpt.com (Accessed: 20 August 2025).

[24] World Health Organization. Alarming decline in adolescent condom use, increased risk of sexually transmitted infections and unintended pregnancies, reveals new WHO report. 2024. Available at: https://www.who.int/europe/news/item/29-08-2024-alarming-decline-in-adolescent-condom-use--increased-risk-of-sexually-transmitted-infections-and-unintended-pregnancies--reveals-new-who-report (Accessed: 20 August 2025).

[25] Cantero Pérez P, Klingemann J, Yaron M, Irion NF, Streuli I. Contraception during the perimenopause: indications, security, and non contraceptive benefits. Revue Médicale Suisse. 2015; 11: 1986, 1988–1992. (In French)


Submission Turnaround Time

Top